StockData
Nexalin Technology, Inc. logo

Nexalin Technology, Inc. (NXL) stock

NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.44−0.06 (-4.00%)

Close on Nov 18, 2026Market cap $31.73MP/E –Yield –

Nexalin Technology cash

Cash and short-term investments held at the end of each period.

Nexalin Technology's cash was $1.00M at Jun 30, 2026. For fiscal 2025 it was $3.72M, up 7.0% from the year before. The highest annual figure on record is $6.99M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.72M+7.0%
FY2024Dec 31, 2024$3.48M+18.0%
FY2023Dec 31, 2023$2.95M-57.8%
FY2022Dec 31, 2022$6.99M+956.8%
FY2021Dec 31, 2021$661.78K+743.7%
FY2020Dec 31, 2020$78.44K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.00M-82.7%
Q1 FY2026Mar 31, 2026$2.71M+32.1%
Q4 FY2025Dec 31, 2025$3.72M+7.0%
Q3 FY2025Sep 30, 2025$4.35M-5.2%
Q2 FY2025Jun 30, 2025$5.79M+582.5%
Q1 FY2025Mar 31, 2025$2.05M-4.3%
Q4 FY2024Dec 31, 2024$3.48M+18.0%
Q3 FY2024Sep 30, 2024$4.59M-2.2%
Q2 FY2024Jun 30, 2024$848.80K-84.5%
Q1 FY2024Mar 31, 2024$2.14M-69.3%
Q4 FY2023Dec 31, 2023$2.95M-62.5%
Q2 FY2023Jun 30, 2023$4.70M+1512.1%
Q1 FY2023Mar 31, 2023$5.47M+1093.3%
Q4 FY2022Dec 31, 2022$6.99M+956.8%
Q3 FY2022Sep 30, 2022$7.86M+5664.4%
Q2 FY2022Jun 30, 2022$291.34K+271.4%
Q1 FY2022Mar 31, 2022$458.61K–
Q4 FY2021Dec 31, 2021$661.78K–
Q3 FY2021Sep 30, 2021$136.43K–
Q4 FY2020Dec 31, 2020$78.44K–

More Nexalin Technology figures

See a number that looks wrong?